Aspire Biopharma Holdings (ASBP) Debt Ratio (2023 - 2026)

Aspire Biopharma Holdings (ASBP) has 4 years of Debt Ratio data on file, last reported at 0.07 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 72.38% year-over-year to 0.07 in Q1 2026; TTM through Mar 2026 was 0.07, a 72.38% decrease from a year earlier, with the FY2025 full-year figure at 2.13, down 92.29% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.07, down from 2.13 in the prior quarter.
• Over the last five years, Debt Ratio for ASBP reached as high as 27.59 in Q4 2024 and fell as low as 0.0 in Q4 2023.
• Historically, Debt Ratio has averaged 3.63 across 4 years, with a median of 0.25 in 2025.
• Across the five-year window, Debt Ratio soared 2225929.64% in 2024 and sank 92.29% in 2025, its largest moves.
• Year by year, Debt Ratio stood at 0.0 in 2023, then surged by 2225929.64% to 27.59 in 2024, then sank by 92.29% to 2.13 in 2025, then plunged by 96.7% to 0.07 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.07 in Q1 2026, 2.13 in Q4 2025, and 1.97 in Q3 2025.